Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance set » significance _ (Expand Search), significance level (Expand Search)
set decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significance set » significance _ (Expand Search), significance level (Expand Search)
set decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
-
2381
-
2382
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2383
-
2384
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2385
-
2386
-
2387
-
2388
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2389
-
2390
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2391
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2392
-
2393
-
2394
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2395
-
2396
-
2397
-
2398
-
2399
-
2400